Medication Assisted Treatment for Opioid Use Disorder - The Therapists's Role
Topics
- Overview of FDA-approved for opioid use disorder (MOUD)
- Research supporting each of the medications
- Addressing stigma and misconceptions about MOUD
- Supporting clients in medication adherence and recovery
Learning Objectives
- By the end of the session, participants will be able to accurately describe the differences between buprenorphine, methadone, and naltrexone treatments for opioid use disorder.
- Participants will be able to identify at least one client characteristic that would make them a potential candidate for each medication.
- Participants will be able to explain why medication assisted treatment with methadone or buprenorphine is not just addiction to another substance (i.e. contrary to this stigma).